https://orcid.org/0000-0001-7658-9251
About the Authors
- Safia Sharif
-
Roles Supervision, Writing – original draft
Affiliation Psychopharmacology, Substance Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
- Suzanne Fergus
-
Roles Supervision
* E-mail: S.Fergus@herts.ac.uk (SF); Amira.guirguis@swansea.ac.uk (AG)
Affiliation Psychopharmacology, Substance Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
- Amira Guirguis
-
Roles Supervision
* E-mail: S.Fergus@herts.ac.uk (SF); Amira.guirguis@swansea.ac.uk (AG)
Affiliations Psychopharmacology, Substance Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, Institute of Life Sciences 2, Swansea University, Swansea, Wales, United Kingdom
- Nigel Smeeton
-
Roles Formal analysis
Affiliation Centre for Research in Public Health and Community Care, School of Health and Social Work, University of Hertfordshire, Hatfield, United Kingdom
- Fabrizio Schifano
-
Roles Supervision
Affiliation Psychopharmacology, Substance Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
Competing Interests
FS was a previous (2011–2019) member of the ACMD UK; he is currently a member of the European Medicines Agency (EMA) Psychiatry Advisory Board. These memberships did not alter our adherence to PLOS ONE policies on sharing data and materials.